The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR
- 1 October 1995
- journal article
- research article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 6 (8), 811-816
- https://doi.org/10.1093/oxfordjournals.annonc.a059321
Abstract
Background: The tumor suppressor gene wt-1 was isolated by cytogenetic deletion analysis of patients with Wilms' tumor (wt-1). This gene encodes for a zinc finger DNA-bind-ing protein with transcription-repressing properties. During normal ontogenesis it is expressed in a time- and tissue-dependent manner mainly in the kidneys and gonads. Recently, the expression of wt-1 in acute leukemias (AL) was reported. Here we investigated the prognostic potential of wt-1 mRNA expression during the course of the disease using the PCR technique. Patients and methods: Blast cells from 83 patients with newly diagnosed AML and 20 AML patients during follow-up in complete remission were analyzed for wt-1 mRNA expression. Peripheral blood mononuclear cells (PBMNC) and bone marrow (BM) from healthy persons (n = 13) and sorted CD34-positive cells from normal donors (n = 4) were used as negative controls Results: Wt-1-specific m-RNA was detectable in 67/83 (81%) patients with AML. Normal donors did not express wt-1 m-RNA but in 1/4 sorted CD34+ cell samples a weak amplified product was observed. After achieving cytologica] CR 14/20 studied patients lost wt-1 expression. In 7/8 patients in morphological CR the reappearance of wt-1 expression preceded relapse of the disease, in 1/8 patients wt-1 remained positive in CR. Response to therapy, disease-free survival, overall survival and FAB-subtype did not correlate with wt-1 m-RNA expression in newly diagnosed AML before therapy Conclusions: In the majority of acute leukemias wt-1 is expressed and probably blast cell-associated, at least in levels detectable by PCR. Wt-1 mRNA was detectable in bone marrow cells of AML patients in clinical CR The results strongly suggest that the persistence or reappearance of wt-1 predicts relapse of the disease prior to morphological relapseKeywords
This publication has 20 references indexed in Scilit:
- Interleukin-2 Bolus Infusion as Late Consolidation Therapy in 2nd Remission of Acute Myeloblastic LeukemiaLeukemia & Lymphoma, 1995
- Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1Science, 1992
- The candidate Wilms' tumour gene is involved in genitourinary developmentNature, 1990
- An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumorCell, 1990
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990
- A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarizationCell, 1988
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958